DiaSorin and QIAGEN sign collaboration to expand liaison test menu through adoption of select QIAGEN assays

French health-system approves reimbursement of QIAGEN's QuantiFERON latent TB test 

QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies

QIAGEN expands biomarker content portfolio to support greater use of molecular diagnostics for immuno-oncology therapies

QIAGEN reports results for first quarter 2017

QIAGEN partners with Maccura to localize and commercialize GeneReader NGS System in China

New research suggests potential for additional clinical utility of QIAGEN’s QuantiFERON-TB Gold Plus

QIAGEN’s GeneReader NGS System gains further validation in oncology research applications with new independent performance review data

QIAGEN expands liquid biopsy pipeline with AR-V7 test in prostate cancer